FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058954571> ?p ?o ?g. }

• W2058954571 endingPage "522" @default.
• W2058954571 startingPage "515" @default.
• W2058954571 abstract "Pharmacological treatment of type 2 diabetes has been enriched during recent years, with the launch of incretin therapies targeting glucagon-like peptide-1 (GLP-1). Such medications comprise either GLP-1 receptor agonists, with short (one or two daily injections: exenatide, liraglutide, lixisenatide) or long duration (one injection once weekly: extended-released exenatide, albiglutide, dulaglutide, taspoglutide); or oral compounds inhibiting dipeptidyl peptidase-4 (DPP-4), the enzyme that inactives GLP-1, also called gliptins (sitagliptin, vildagliptin, saxagliptin, linagliptin, alogliptin). Although both pharmacological approaches target GLP-1, important differences exist concerning the mode of administration (subcutaneous injection versus oral ingestion), the efficacy (better with GLP-1 agonists), the effects on body weight and systolic blood pressure (diminution with agonists versus neutrality with gliptins), the tolerance profile (nausea and possibly vomiting with agonists) and the cost (higher with GLP-1 receptor agonists). Both agents may exert favourable cardiovascular effects. Gliptins may represent a valuable alternative to a sulfonylurea or a glitazone after failure of monotherapy with metformin while GLP-1 receptor agonists may be considered as a good alternative to insulin (especially in obese patients) after failure of a dual oral therapy. However, this scheme is probably too restrictive and modalities of using incretins are numerous, in almost all stages of type 2 diabetes. Physicians may guide the pharmacological choice based on clinical characteristics, therapeutic goals and patient's preference." @default.
• W2058954571 created "2016-06-24" @default.
• W2058954571 creator A5039563874 @default.
• W2058954571 date "2013-12-01" @default.
• W2058954571 modified "2023-09-23" @default.
• W2058954571 title "GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician?" @default.
• W2058954571 cites W1220137049 @default.
• W2058954571 cites W1518543897 @default.
• W2058954571 cites W1547073044 @default.
• W2058954571 cites W1559082056 @default.
• W2058954571 cites W188703145 @default.
• W2058954571 cites W1967096313 @default.
• W2058954571 cites W1975591028 @default.
• W2058954571 cites W1978191819 @default.
• W2058954571 cites W198655243 @default.
• W2058954571 cites W1991670435 @default.
• W2058954571 cites W2002961599 @default.
• W2058954571 cites W2004932692 @default.
• W2058954571 cites W2007910256 @default.
• W2058954571 cites W2009969219 @default.
• W2058954571 cites W2016542902 @default.
• W2058954571 cites W2016726554 @default.
• W2058954571 cites W2019530565 @default.
• W2058954571 cites W2027276740 @default.
• W2058954571 cites W2029071587 @default.
• W2058954571 cites W2030228579 @default.
• W2058954571 cites W2030484664 @default.
• W2058954571 cites W2031848004 @default.
• W2058954571 cites W2042661216 @default.
• W2058954571 cites W2043226477 @default.
• W2058954571 cites W2045271826 @default.
• W2058954571 cites W2052771129 @default.
• W2058954571 cites W2058514432 @default.
• W2058954571 cites W2063040422 @default.
• W2058954571 cites W2067736115 @default.
• W2058954571 cites W2068059840 @default.
• W2058954571 cites W2072691447 @default.
• W2058954571 cites W2073841569 @default.
• W2058954571 cites W2085458648 @default.
• W2058954571 cites W2086177834 @default.
• W2058954571 cites W2092287139 @default.
• W2058954571 cites W2094195067 @default.
• W2058954571 cites W2098674879 @default.
• W2058954571 cites W2103075451 @default.
• W2058954571 cites W2107949845 @default.
• W2058954571 cites W2108646121 @default.
• W2058954571 cites W2111876001 @default.
• W2058954571 cites W2112981414 @default.
• W2058954571 cites W2113367996 @default.
• W2058954571 cites W2119592108 @default.
• W2058954571 cites W2126703310 @default.
• W2058954571 cites W2134806962 @default.
• W2058954571 cites W2139562487 @default.
• W2058954571 cites W2141132900 @default.
• W2058954571 cites W2143014102 @default.
• W2058954571 cites W2147187810 @default.
• W2058954571 cites W2149762820 @default.
• W2058954571 cites W2150359377 @default.
• W2058954571 cites W2158576041 @default.
• W2058954571 cites W2159198773 @default.
• W2058954571 cites W2159205789 @default.
• W2058954571 cites W2166580699 @default.
• W2058954571 cites W2167777458 @default.
• W2058954571 cites W2012312800 @default.
• W2058954571 doi "https://doi.org/10.1016/j.ando.2012.06.002" @default.
• W2058954571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23570814" @default.
• W2058954571 hasPublicationYear "2013" @default.
• W2058954571 type Work @default.
• W2058954571 sameAs 2058954571 @default.
• W2058954571 citedByCount "20" @default.
• W2058954571 countsByYear W20589545712014 @default.
• W2058954571 countsByYear W20589545712015 @default.
• W2058954571 countsByYear W20589545712016 @default.
• W2058954571 countsByYear W20589545712017 @default.
• W2058954571 countsByYear W20589545712018 @default.
• W2058954571 countsByYear W20589545712019 @default.
• W2058954571 countsByYear W20589545712023 @default.
• W2058954571 crossrefType "journal-article" @default.
• W2058954571 hasAuthorship W2058954571A5039563874 @default.
• W2058954571 hasBestOaLocation W20589545712 @default.
• W2058954571 hasConcept C126322002 @default.
• W2058954571 hasConcept C134018914 @default.
• W2058954571 hasConcept C148001335 @default.
• W2058954571 hasConcept C156490143 @default.
• W2058954571 hasConcept C170493617 @default.
• W2058954571 hasConcept C185280430 @default.
• W2058954571 hasConcept C2776433454 @default.
• W2058954571 hasConcept C2776453732 @default.
• W2058954571 hasConcept C2777180221 @default.
• W2058954571 hasConcept C2778881409 @default.
• W2058954571 hasConcept C2778938600 @default.
• W2058954571 hasConcept C2779284873 @default.
• W2058954571 hasConcept C2779829264 @default.
• W2058954571 hasConcept C2780031085 @default.
• W2058954571 hasConcept C2780282729 @default.
• W2058954571 hasConcept C2780323712 @default.
• W2058954571 hasConcept C2780533449 @default.
• W2058954571 hasConcept C2781308992 @default.

• next